Cargando…

Quantifying the impact of SARS-CoV-2 temporal vaccination trends and disparities on disease control

SARS-CoV-2 vaccines have been distributed at unprecedented speed. Still, little is known about temporal vaccination trends, their association with socioeconomic inequality, and their consequences for disease control. Using data from 161 countries/territories and 58 states, we examined vaccination ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Sophie L., Shin, Ikgyu, Joseph, Jefrin, West, Haylee, Anorga, Rafael, Mena, Gonzalo E., Mahmud, Ayesha S., Martinez, Pamela P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396293/
https://www.ncbi.nlm.nih.gov/pubmed/37531439
http://dx.doi.org/10.1126/sciadv.adh9920
_version_ 1785083728289071104
author Larsen, Sophie L.
Shin, Ikgyu
Joseph, Jefrin
West, Haylee
Anorga, Rafael
Mena, Gonzalo E.
Mahmud, Ayesha S.
Martinez, Pamela P.
author_facet Larsen, Sophie L.
Shin, Ikgyu
Joseph, Jefrin
West, Haylee
Anorga, Rafael
Mena, Gonzalo E.
Mahmud, Ayesha S.
Martinez, Pamela P.
author_sort Larsen, Sophie L.
collection PubMed
description SARS-CoV-2 vaccines have been distributed at unprecedented speed. Still, little is known about temporal vaccination trends, their association with socioeconomic inequality, and their consequences for disease control. Using data from 161 countries/territories and 58 states, we examined vaccination rates across high and low socioeconomic status (SES), showing that disparities in coverage exist at national and subnational levels. We also identified two distinct vaccination trends: a rapid initial rollout, quickly reaching a plateau, or sigmoidal and slow to begin. Informed by these patterns, we implemented an SES-stratified mechanistic model, finding profound differences in mortality and incidence across these two vaccination types. Timing of initial rollout affects disease outcomes more substantially than final coverage or degree of SES disparity. Unexpectedly, timing is not associated with wealth inequality or GDP per capita. While socioeconomic disparity should be addressed, accelerating initial rollout for all over focusing on increasing coverage is an accessible intervention that could minimize the burden of disease across socioeconomic groups.
format Online
Article
Text
id pubmed-10396293
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-103962932023-08-03 Quantifying the impact of SARS-CoV-2 temporal vaccination trends and disparities on disease control Larsen, Sophie L. Shin, Ikgyu Joseph, Jefrin West, Haylee Anorga, Rafael Mena, Gonzalo E. Mahmud, Ayesha S. Martinez, Pamela P. Sci Adv Social and Interdisciplinary Sciences SARS-CoV-2 vaccines have been distributed at unprecedented speed. Still, little is known about temporal vaccination trends, their association with socioeconomic inequality, and their consequences for disease control. Using data from 161 countries/territories and 58 states, we examined vaccination rates across high and low socioeconomic status (SES), showing that disparities in coverage exist at national and subnational levels. We also identified two distinct vaccination trends: a rapid initial rollout, quickly reaching a plateau, or sigmoidal and slow to begin. Informed by these patterns, we implemented an SES-stratified mechanistic model, finding profound differences in mortality and incidence across these two vaccination types. Timing of initial rollout affects disease outcomes more substantially than final coverage or degree of SES disparity. Unexpectedly, timing is not associated with wealth inequality or GDP per capita. While socioeconomic disparity should be addressed, accelerating initial rollout for all over focusing on increasing coverage is an accessible intervention that could minimize the burden of disease across socioeconomic groups. American Association for the Advancement of Science 2023-08-02 /pmc/articles/PMC10396293/ /pubmed/37531439 http://dx.doi.org/10.1126/sciadv.adh9920 Text en Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Social and Interdisciplinary Sciences
Larsen, Sophie L.
Shin, Ikgyu
Joseph, Jefrin
West, Haylee
Anorga, Rafael
Mena, Gonzalo E.
Mahmud, Ayesha S.
Martinez, Pamela P.
Quantifying the impact of SARS-CoV-2 temporal vaccination trends and disparities on disease control
title Quantifying the impact of SARS-CoV-2 temporal vaccination trends and disparities on disease control
title_full Quantifying the impact of SARS-CoV-2 temporal vaccination trends and disparities on disease control
title_fullStr Quantifying the impact of SARS-CoV-2 temporal vaccination trends and disparities on disease control
title_full_unstemmed Quantifying the impact of SARS-CoV-2 temporal vaccination trends and disparities on disease control
title_short Quantifying the impact of SARS-CoV-2 temporal vaccination trends and disparities on disease control
title_sort quantifying the impact of sars-cov-2 temporal vaccination trends and disparities on disease control
topic Social and Interdisciplinary Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396293/
https://www.ncbi.nlm.nih.gov/pubmed/37531439
http://dx.doi.org/10.1126/sciadv.adh9920
work_keys_str_mv AT larsensophiel quantifyingtheimpactofsarscov2temporalvaccinationtrendsanddisparitiesondiseasecontrol
AT shinikgyu quantifyingtheimpactofsarscov2temporalvaccinationtrendsanddisparitiesondiseasecontrol
AT josephjefrin quantifyingtheimpactofsarscov2temporalvaccinationtrendsanddisparitiesondiseasecontrol
AT westhaylee quantifyingtheimpactofsarscov2temporalvaccinationtrendsanddisparitiesondiseasecontrol
AT anorgarafael quantifyingtheimpactofsarscov2temporalvaccinationtrendsanddisparitiesondiseasecontrol
AT menagonzaloe quantifyingtheimpactofsarscov2temporalvaccinationtrendsanddisparitiesondiseasecontrol
AT mahmudayeshas quantifyingtheimpactofsarscov2temporalvaccinationtrendsanddisparitiesondiseasecontrol
AT martinezpamelap quantifyingtheimpactofsarscov2temporalvaccinationtrendsanddisparitiesondiseasecontrol